Nancy Bartlett

2023

Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma

Nastoupil, L. J. & Bartlett, N. L., Feb 1 2023, In: Journal of Clinical Oncology. 41, 4, p. 903-913 11 p.

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

2021

Optimizing Second-Line Therapy for Hodgkin Lymphoma: A Work in Progress

Bartlett, N. L., Oct 1 2021, In: Journal of Clinical Oncology. 39, 28, p. 3097-3103 7 p.

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

2020

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

Thanarajasingam, G., Leonard, J. P., Witzig, T. E., Habermann, T. M., Blum, K. A., Bartlett, N. L., Flowers, C. R., Pitcher, B. N., Jung, S. H., Atherton, P. J., Tan, A., Novotny, P. J. & Dueck, A. C., Jun 2020, In: The Lancet Haematology. 7, 6, p. e490-e497

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

2018

CD19-targeted immunotherapies for treatment of patients with non-Hodgkin B-cell lymphomas

Watkins, M. P. & Bartlett, N. L., Jul 3 2018, In: Expert Opinion on Investigational Drugs. 27, 7, p. 601-611 11 p.

Research output: Contribution to journal › Review article › peer-review

21 Scopus citations

SOHO State of the Art Updates and Next Questions: Hodgkin Lymphoma

Watkins, M. P., Fanale, M. A. & Bartlett, N. L., Feb 2018, In: Clinical Lymphoma, Myeloma and Leukemia. 18, 2, p. 81-90 10 p.

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

2017

Hodgkin lymphoma: Current status and clinical trial recommendations

Diefenbach, C. S., Connors, J. M., Friedberg, J. W., Leonard, J. P., Kahl, B. S., Little, R. F., Baizer, L., Evens, A. M., Hoppe, R. T., Kelly, K. M., Persky, D. O., Younes, A., Kostakaglu, L. & Bartlett, N. L., Apr 2017, In: Journal of the National Cancer Institute. 109, 4

Research output: Contribution to journal › Review article › peer-review

Open Access

25 Scopus citations

NCCN guidelines® insights chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017: Featured updates to the NCCN guidelines

Wierda, W. G., Zelenetz, A. D., Gordon, L. I., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Caimi, P., Fayad, L. E., Fisher, R. I., Glenn, M. J., Habermann, T. M., Harris, N. L., Hernandez-Ilizaliturri, F., Hoppe, R. T., Horwitz, S. M., Kaminski, M. S., Kelsey, C. R., Kim, Y. H., & 18 othersKrivacic, S., LaCasce, A. S., Martin, M. G., Nademanee, A., Porcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Roberts, K., Saad, A. A., Snyder, E. D., Sokol, L., Swinnen, L. J., Vose, J. M., Yahalom, J., Dwyer, M. A. & Sundar, H., Mar 1 2017, In: JNCCN Journal of the National Comprehensive Cancer Network. 15, 3, p. 293-311 19 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

47 Scopus citations

2016

Diffuse large b-cell lymphoma version 1.2016: Clinical practice guidelines in oncology

Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Fayad, L. E., Fisher, R. I., Glenn, M. J., Habermann, T. M., Harris, N. L., Hernandez-Ilizaliturri, F., Hoppe, R. T., Horwitz, S. M., Kaminski, M. S., Kelsey, C. R., Kim, Y. H., Krivacic, S., & 17 othersLaCasce, A. S., Lunning, M., Nademanee, A., Porcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Roberts, K., Saad, A. A., Sokol, L., Swinnen, L. J., Vose, J. M., Yahalom, J., Zafar, N., Dwyer, M. & Sundar, H., Feb 1 2016, In: JNCCN Journal of the National Comprehensive Cancer Network. 14, 2, p. 196-231 36 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

70 Scopus citations

NCCN Guidelines® insights: Non-Hodgkin's lymphomas, version 3.2016 featured updates to the NCCN guidelines

Horwitz, S. M., Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Fayad, L. E., Fisher, R. I., Glenn, M. J., Habermann, T. M., Harris, N. L., Hernandez-Ilizaliturri, F., Hoppe, R. T., Kaminski, M. S., Kelsey, C. R., Kim, Y. H., Krivacic, S., & 17 othersLa Casce, A. S., Lunning, M., Nademanee, A., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Roberts, K., Saad, A. A., Sokol, L., Swinnen, L. J., Vose, J. M., Yahalom, J., Zafar, N., Dwyer, M., Sundar, H. & Porcu, P., Sep 2016, In: JNCCN Journal of the National Comprehensive Cancer Network. 14, 9, p. 1067-1079 13 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

102 Scopus citations

2015

Biologic agents in the management of Hodgkin lymphoma

Rashidi, A. & Bartlett, N. L., May 1 2015, In: JNCCN Journal of the National Comprehensive Cancer Network. 13, 5, p. 587-596 10 p.

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Blinatumomab for the treatment of B-cell lymphoma

Oak, E. & Bartlett, N. L., May 1 2015, In: Expert Opinion on Investigational Drugs. 24, 5, p. 715-724 10 p.

Research output: Contribution to journal › Review article › peer-review

26 Scopus citations

Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015

Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Fisher, R. I., Glenn, M. J., Habermann, T. M., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kelsey, C. R., Kim, Y. H., Krivacic, S., LaCasce, A. S., & 16 othersNademanee, A., Porcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Saad, A. A., Sokol, L., Swinnen, L. J., Tsien, C., Vose, J. M., Wilson, L., Yahalom, J., Zafar, N., Dwyer, M. & Sundar, H., Mar 1 2015, In: JNCCN Journal of the National Comprehensive Cancer Network. 13, 3, p. 326-362 37 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

45 Scopus citations

2014

Non-Hodgkin's lymphomas, version 2.2014

Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Fisher, R. I., Glenn, M. J., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kelsey, C. R., Kim, Y. H., Krivacic, S., LaCasce, A. S., & 14 othersNademanee, A., Porcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Sokol, L., Swinnen, L. J., Tsien, C., Vose, J. M., Yahalom, J., Zafar, N., Dwyer, M. & Sundar, H., Jun 1 2014, In: JNCCN Journal of the National Comprehensive Cancer Network. 12, 6, p. 916-946 31 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

58 Scopus citations

Non-Hodgkin's lymphomas, version 4.2014

Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Fisher, R. I., Glenn, M. J., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kelsey, C. R., Kim, Y. H., Krivacic, S., LaCasce, A. S., Nademanee, A., & 14 othersPorcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Saad, A. A., Sokol, L., Swinnen, L. J., Tsien, C., Vose, J. M., Yahalom, J., Zafar, N., Dwyer, M. & Sundar, H., Sep 1 2014, In: JNCCN Journal of the National Comprehensive Cancer Network. 12, 9, p. 1282-1303 22 p.

Research output: Contribution to journal › Review article › peer-review

100 Scopus citations

Rituximab is associated with improved survival in Burkitt lymphoma: A retrospective analysis from two US academic medical centers

Wildes, T. M., Farrington, L., Yeung, C., Harrington, A. M., Foyil, K. V., Liu, J., Bartlett, N. L., Kreisel, F. & Fenske, T. S., Feb 2014, In: Therapeutic Advances in Hematology. 5, 1, p. 3-12 10 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

18 Scopus citations

2013

Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy

Bartlett, N. L., 2013, In: American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting. p. 374-380 7 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

6 Scopus citations

Non-Hodgkin's lymphomas, version 1.2013: Featured updates to the NCCN guidelines

Zelenetz, A. D., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Glenn, M. J., Gockerman, J. P., Gordon, L. I., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Christopher, R. K., Kim, Y. H., Krivacic, S., LaCasce, A. S., & 13 othersNademanee, A., Porcu, P., Press, O., Pro, B., Reddy, N., Sokol, L., Swinnen, L., Tsien, C., Vose, J. M., Yahalom, J., Zafar, N., Dwyer, M. A. & Naganuma, M., Mar 1 2013, In: JNCCN Journal of the National Comprehensive Cancer Network. 11, 3, p. 257-273 17 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

52 Scopus citations

Treatment of nodular lymphocyte-predominant hodgkinlymphoma-"do no harm"

Bartlett, N. L., Jun 1 2013, In: Clinical Advances in Hematology and Oncology. 11, 6

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

2012

Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma

Foyil, K. V. & Bartlett, N. L., Sep 2012, In: Cancer Journal (United States). 18, 5, p. 450-456 7 p.

Research output: Contribution to journal › Review article › peer-review

44 Scopus citations

Commentary

Bartlett, N. L., Jul 1 2012, In: Clinical Advances in Hematology and Oncology. 10, 7, p. 470-471 2 p.

Research output: Contribution to journal › Review article › peer-review

Non-Hodgkin's Lymphomas, version 3.2012: Featured updates to the NCCN guidelines

Zelenetz, A. D., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., Byrd, J. C., Czuczman, M. S., Fayad, L., Glenn, M. J., Gockerman, J. P., Gordon, L. I., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kelsey, C. R., Kim, Y. H., Krivacic, S., LaCasce, A. S., & 13 othersNademanee, A., Porcu, P., Press, O., Pro, B., Reddy, N., Sokol, L., Swinnen, L., Tsien, C., Vose, J. M., Yahalom, J., Zafar, N., Naganuma, M. & Dwyer, M. A., Dec 1 2012, In: JNCCN Journal of the National Comprehensive Cancer Network. 10, 12, p. 1487-1498 12 p.

Research output: Contribution to journal › Review article › peer-review

31 Scopus citations

2011

Brentuximab vedotin for the treatment of CD30⁺ lymphomas

Foyil, K. V. & Bartlett, N. L., Apr 1 2011, In: Immunotherapy. 3, 4, p. 475-485 11 p.

Research output: Contribution to journal › Review article › peer-review

35 Scopus citations

Non-Hodgkin's lymphomas: Clinical practice guidelines in oncology

Zelenetz, A. D., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Glenn, M. J., Gockerman, J. P., Gordon, L. I., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kelsey, C. R., Kim, Y. H., LaCasce, A. S., Nademanee, A., Porcu, P., & 10 othersPress, O., Pro, B., Reddy, N., Sokol, L., Swinnen, L. J., Tsien, C., Vose, J. M., Wierda, W. G., Yahalom, J. & Zafar, N., May 1 2011, In: JNCCN Journal of the National Comprehensive Cancer Network. 9, 5, p. 484-560 77 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

56 Scopus citations

2010

Anti-CD30 antibodies for Hodgkin lymphoma

Foyil, K. V. & Bartlett, N. L., Jul 2010, In: Current Hematologic Malignancy Reports. 5, 3, p. 140-147 8 p.

Research output: Contribution to journal › Review article › peer-review

41 Scopus citations

The present: optimizing therapy--too much or too little?

Bartlett, N. L., 2010, In: Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2010, p. 108-114 7 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

5 Scopus citations

2009

Drug development for recurrent and refractory classical Hodgkin lymphoma

Wildes, T. M. & Bartlett, N. L., 2009, In: Leukemia and Lymphoma. 50, 4, p. 529-540 12 p.

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

2008

Modern treatment of Hodgkin lymphoma

Bartlett, N. L., Jul 2008, In: Current opinion in hematology. 15, 4, p. 408-414 7 p.

Research output: Contribution to journal › Review article › peer-review

20 Scopus citations

Salvage regimens for Hodgkin lymphoma

Cashen, A. F. & Bartlett, N. L., Jul 2008, In: Clinical Advances in Hematology and Oncology. 6, 7, p. 517-524 8 p.

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

2006

Management of advanced stage Hodgkin's lymphoma.

Bartlett, N. L. & Smukler, A. J., 2006, In: Cancer treatment and research. 131, p. 333-352 20 p.

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

2004

⁹⁰Yttrium-ibritumomab tiuxetan: A novel treatment for non-Hodgkin's lymphoma

Blum, K. A. & Bartlett, N. L., Aug 2004, In: Expert opinion on biological therapy. 4, 8, p. 1323-1331 9 p.

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

2000

Hodgkin's disease: prognostic factors and short-course regimens.

Bartlett, N. L. & Arackal, S. M., Mar 2000, In: Current oncology reports. 2, 2, p. 163-171 9 p.

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Treatment advances in non-Hodgkin's lymphoma

Tan, B. R. & Bartlett, N. L., Mar 2000, In: Expert Opinion on Pharmacotherapy. 1, 3, p. 451-465 15 p.

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

1999

Non-Hodgkin's lymphomas.

Bartlett, N. L. & Wagner, N. D., 1999, In: Cancer chemotherapy and biological response modifiers. 18, p. 293-323 31 p.

Research output: Contribution to journal › Review article › peer-review

1997

Treatment of aggressive histology lymphoma

Bartlett, N. L., Jan 1 1997, In: Current Opinion in Oncology. 9, 5, p. 413-419 7 p.

Research output: Contribution to journal › Review article › peer-review

1991

Serum markers in germ cell neoplasms

Bartlett, N. L., Freiha, F. S. & Torti, F. M., 1991, In: Hematology/Oncology Clinics of North America. 5, 6, p. 1245-1260 16 p.

Research output: Contribution to journal › Review article › peer-review

35 Scopus citations

Nancy Bartlett

Research output

Search results